Arrowstreet Capital, Limited Partnership Xencor Inc Put Options Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
204Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$225 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$185 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$142 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$108 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$80.2 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.21B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...